A Pharmacokinetic Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Hepatic Impairment
Interventions: DRUG: Elacestrant dihydrochloride
Sponsor: Stemline Therapeutics, Inc.